These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4051150)

  • 41. Effects of neostigmine or edrophonium on force of contraction when administered at a train-of-four ratio of 0.9 in anesthetized dogs.
    Romano M; Martin-Flores M; Sakai DM; Tseng CT; Campoy L; Gleed RD
    Vet Anaesth Analg; 2017 Nov; 44(6):1313-1320. PubMed ID: 29066245
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Profound atracurium induced neuromuscular blockade. A comparison of evoked reversal with edrophonium or neostigmine.
    Casson WR; Jones RM
    Anaesthesia; 1986 Apr; 41(4):382-5. PubMed ID: 3754698
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mechanical responses to peroneal nerve stimulation in halothane-anesthetized horses in the absence of neuromuscular blockade and during partial nondepolarizing blockade.
    Klein C; Hopkins J; Beck E; Burton B
    Am J Vet Res; 1983 May; 44(5):781-5. PubMed ID: 6869983
    [No Abstract]   [Full Text] [Related]  

  • 44. Different properties of the bradycardia produced by neostigmine and edrophonium in the cat.
    Backman SB; Stein RD; Blank DW; Collier B; Polosa C
    Can J Anaesth; 1996 Jul; 43(7):731-40. PubMed ID: 8807181
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antagonism of vecuronium and atracurium: comparison of neostigmine and edrophonium administered at 5% twitch height recovery.
    Caldwell JE; Robertson EN; Baird WL
    Br J Anaesth; 1987 Apr; 59(4):478-81. PubMed ID: 2882769
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neostigmine and edrophonium for reversal of pipecuronium neuromuscular blockade.
    Abdulatif M; Naguib M
    Can J Anaesth; 1991 Mar; 38(2):159-63. PubMed ID: 1850665
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Edrophonium priming alters the course of neuromuscular recovery from a pipecuronium neuromuscular blockade.
    Naguib M; Abdulatif M
    Can J Anaesth; 1991 Sep; 38(6):722-7. PubMed ID: 1655299
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antagonism of org NC 45 (vecuronium) and pancuronium neuromuscular blockade by neostigmine.
    Gencarelli PJ; Miller RD
    Br J Anaesth; 1982 Jan; 54(1):53-6. PubMed ID: 6119998
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interaction of 2,4-diaminopyridine with cholinesterase inhibitors.
    Biessels PT; Houwertjes MC; Agoston S; Horn AS
    Arch Int Pharmacodyn Ther; 1988; 293():228-35. PubMed ID: 3421780
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Edrophonium antagonizes combined lidocaine-pancuronium and verapamil-pancuronium neuromuscular blockade in cats.
    Carpenter RL; Mulroy MF
    Anesthesiology; 1986 Nov; 65(5):506-10. PubMed ID: 3777479
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Edrophonium: duration of action and atropine requirement in humans during halothane anesthesia.
    Cronnelly R; Morris RB; Miller RD
    Anesthesiology; 1982 Oct; 57(4):261-6. PubMed ID: 7125261
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A comparison of edrophonium and neostigmine for the antagonism of atracurium-induced neuromuscular block.
    Lavery GG; Mirakhur RK; Gibson FM
    Anesth Analg; 1985 Sep; 64(9):867-70. PubMed ID: 3161421
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neuromuscular blocking effects of vecuronium and pancuronium during halothane anaesthesia.
    Engbaek J; Ording H; Viby-Mogensen J
    Br J Anaesth; 1983 Jun; 55(6):497-500. PubMed ID: 6134535
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antagonism of pancuronium and its metabolites by neostigmine in cats.
    Booij LH; Miller RD; Jones MJ; Stanski DR
    Anesth Analg; 1979; 58(6):483-6. PubMed ID: 574733
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antagonism of Org NC 45 neuromuscular blockade by neostigmine, pyridostigmine, and 4-aminopyridine.
    Booij LH; van der Pol F; Crul JF; Miller RD
    Anesth Analg; 1980 Jan; 59(1):31-4. PubMed ID: 7188663
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antagonism of pancuronium in renal failure: no recurarization.
    Bevan DR; Archer D; Donati F; Ferguson A; Higgs BD
    Br J Anaesth; 1982 Jan; 54(1):63-8. PubMed ID: 6275872
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Atropine-edrophonium mixture: a dose-response study.
    Naguib M; Gomaa M; Absood GH
    Anesth Analg; 1988 Jul; 67(7):650-5. PubMed ID: 3382038
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Metabolites of neostigmine and pyridostigmine do not contribute to antagonism of neuromuscular blockade in the dog.
    Hennis PJ; Cronnelly R; Sharma M; Fisher DM; Miller RD
    Anesthesiology; 1984 Nov; 61(5):534-9. PubMed ID: 6149707
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antagonism of atracurium-induced neuromuscular blockade by neostigmine or edrophonium.
    Astley BA; Hughes R; Payne JP
    Br J Anaesth; 1986 Nov; 58(11):1290-5. PubMed ID: 3778793
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recovery characteristics following antagonism of atracurium with neostigmine or edrophonium.
    Jones RM; Pearce AC; Williams JP
    Br J Anaesth; 1984 May; 56(5):453-7. PubMed ID: 6326785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.